Quick Answer
Glycine Sleep Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Data synthesis and subgroup analysis were performed via SMD, WMD, relative risk (RR), and 95% CI to evaluate the effects of rTMS and its influencing factors.
Key Takeaways
- 01Data synthesis and subgroup analysis were performed via SMD, WMD, relative risk (RR), and 95% CI to evaluate the effects of rTMS and its influencing factors. [Cao Z (2026)]
- 02The rTMS group demonstrated markedly improved sleep quality compared with sham rTMS recipients in individuals with insomnia disorder. [Cao Z (2026)]
- 03Conclusion Independent rTMS and rTMS-medication combinations significantly improve sleep patterns and rest quality in patients with Insomnia Disorder. [Cao Z (2026)]
- 04First-line treatments are limited by accessibility or side effects, necessitating alternative approaches. [Cao Z (2026)]
The current Migaku evidence database contains 1 reusable source document for Glycine Sleep Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Data synthesis and subgroup analysis were performed via SMD, WMD, relative risk (RR), and 95% CI to evaluate the effects of rTMS and its influencing factors. [Cao Z (2026); evidence level 1]
- The rTMS group demonstrated markedly improved sleep quality compared with sham rTMS recipients in individuals with insomnia disorder. [Cao Z (2026); evidence level 1]
- Conclusion Independent rTMS and rTMS-medication combinations significantly improve sleep patterns and rest quality in patients with Insomnia Disorder. [Cao Z (2026); evidence level 1]
- First-line treatments are limited by accessibility or side effects, necessitating alternative approaches. [Cao Z (2026); evidence level 1]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources